Market Cap 548.97M
Revenue (ttm) 0.00
Net Income (ttm) -95.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.16
Volume 344,972
Avg Vol 1,034,426
Day's Range N/A - N/A
Shares Out 172.63M
Stochastic %K 62%
Beta 0.52
Analysts Strong Sell
Price Target $9.44

Latest News on SVRA

Savara: Make-It-Or-Break-It Molbreevi BLA Filing

Apr 21, 2025, 11:16 AM EDT - 7 days ago

Savara: Make-It-Or-Break-It Molbreevi BLA Filing


Savara Announces New Employment Inducement Grant

Apr 11, 2025, 4:05 PM EDT - 17 days ago

Savara Announces New Employment Inducement Grant


Savara: The Binary Bet On Phase 3 Data

Jun 7, 2024, 5:56 AM EDT - 11 months ago

Savara: The Binary Bet On Phase 3 Data


Savara to Present at the Jefferies Global Healthcare Conference

May 29, 2024, 8:05 AM EDT - 11 months ago

Savara to Present at the Jefferies Global Healthcare Conference


Savara to Present at Two Upcoming Healthcare Conferences

Jan 31, 2024, 8:05 AM EST - 1 year ago

Savara to Present at Two Upcoming Healthcare Conferences


Savara Added to the NASDAQ Biotechnology Index

Dec 20, 2023, 8:05 AM EST - 1 year ago

Savara Added to the NASDAQ Biotechnology Index


Savara: A Speculative Play

Jul 16, 2023, 11:50 AM EDT - 1 year ago

Savara: A Speculative Play


Savara Added to Russell 3000® Index

Jun 26, 2023, 4:05 PM EDT - 2 years ago

Savara Added to Russell 3000® Index